BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 14991653)

  • 1. Optimization of reovirus production from mouse L-929 cells in suspension culture.
    Jung S; Behie LA; Lee PW; Farrell PJ
    Biotechnol Bioeng; 2004 Mar; 85(7):750-60. PubMed ID: 14991653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-titer adenovirus vector production in 293S cell perfusion culture.
    Cortin V; Thibault J; Jacob D; Garnier A
    Biotechnol Prog; 2004; 20(3):858-63. PubMed ID: 15176892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production of recombinant adeno-associated viral vectors using a baculovirus/insect cell suspension culture system: from shake flasks to a 20-L bioreactor.
    Meghrous J; Aucoin MG; Jacob D; Chahal PS; Arcand N; Kamen AA
    Biotechnol Prog; 2005; 21(1):154-60. PubMed ID: 15903253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimization of virus yield as a strategy to improve rabies vaccine production by Vero cells in a bioreactor.
    Trabelsi K; Rourou S; Loukil H; Majoul S; Kallel H
    J Biotechnol; 2006 Jan; 121(2):261-71. PubMed ID: 16153733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A microcarrier cell culture process for propagating rabies virus in Vero cells grown in a stirred bioreactor under fully animal component free conditions.
    Rourou S; van der Ark A; van der Velden T; Kallel H
    Vaccine; 2007 May; 25(19):3879-89. PubMed ID: 17307281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wave microcarrier cultivation of MDCK cells for influenza virus production in serum containing and serum-free media.
    Genzel Y; Olmer RM; Schäfer B; Reichl U
    Vaccine; 2006 Aug; 24(35-36):6074-87. PubMed ID: 16781022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-glutamine fed-batch cultures of 293-HEK serum-free suspension cells for adenovirus production.
    Lee YY; Yap MG; Hu WS; Wong KT
    Biotechnol Prog; 2003; 19(2):501-9. PubMed ID: 12675594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of a serum-free medium for the growth of Vero cells and the production of reovirus.
    Butler M; Burgener A; Patrick M; Berry M; Moffatt D; Huzel N; Barnabé N; Coombs K
    Biotechnol Prog; 2000; 16(5):854-8. PubMed ID: 11027181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving adeno-associated vector yield in high density insect cell cultures.
    Mena JA; Aucoin MG; Montes J; Chahal PS; Kamen AA
    J Gene Med; 2010 Feb; 12(2):157-67. PubMed ID: 20101623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Viral antigen production in cell cultures on microcarriers Bovine parainfluenza 3 virus and MDBK cells.
    Conceição MM; Tonso A; Freitas CB; Pereira CA
    Vaccine; 2007 Nov; 25(45):7785-95. PubMed ID: 17920165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel control scheme for inducing angiostatin-human IgG fusion protein production using recombinant CHO cells in a oscillating bioreactor.
    Wang IK; Hsieh SY; Chang KM; Wang YC; Chu A; Shaw SY; Ou JJ; Ho L
    J Biotechnol; 2006 Feb; 121(3):418-28. PubMed ID: 16162365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment of a mink enteritis vaccine production process in stirred-tank reactor and Wave Bioreactor microcarrier culture in 1-10 L scale.
    Hundt B; Best C; Schlawin N; Kassner H; Genzel Y; Reichl U
    Vaccine; 2007 May; 25(20):3987-95. PubMed ID: 17391818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum-free influenza virus production avoiding washing steps and medium exchange in large-scale microcarrier culture.
    Genzel Y; Fischer M; Reichl U
    Vaccine; 2006 Apr; 24(16):3261-72. PubMed ID: 16472544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolism of PER.C6 cells cultivated under fed-batch conditions at low glucose and glutamine levels.
    Maranga L; Goochee CF
    Biotechnol Bioeng; 2006 May; 94(1):139-50. PubMed ID: 16523524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of anti-apoptosis genes alters lactate metabolism of Chinese Hamster Ovary cells in culture.
    Dorai H; Kyung YS; Ellis D; Kinney C; Lin C; Jan D; Moore G; Betenbaugh MJ
    Biotechnol Bioeng; 2009 Jun; 103(3):592-608. PubMed ID: 19241388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retroviral vector production using suspension-adapted 293GPG cells in a 3L acoustic filter-based perfusion bioreactor.
    Ghani K; Garnier A; Coelho H; Transfiguracion J; Trudel P; Kamen A
    Biotechnol Bioeng; 2006 Nov; 95(4):653-60. PubMed ID: 16947907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production of reovirus type-1 and type-3 from Vero cells grown on solid and macroporous microcarriers.
    Berry JM; Barnabé N; Coombs KM; Butler M
    Biotechnol Bioeng; 1999 Jan; 62(1):12-9. PubMed ID: 10099508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of a cell-once-through perfusion strategy for production of recombinant antibody from rCHO cells in a Centritech Lab II centrifuge system.
    Kim BJ; Chang HN; Oh DJ
    Biotechnol Prog; 2007; 23(5):1186-97. PubMed ID: 17691812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistent infection with a nontransforming RNA virus leads to impaired growth factor receptors and response.
    Verdin EM; Maratos-Flier E; Carpentier JL; Kahn CR
    J Cell Physiol; 1986 Sep; 128(3):457-65. PubMed ID: 3018005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transient infection of freshly isolated human colorectal tumor cells by reovirus T3D intermediate subviral particles.
    van Houdt WJ; Smakman N; van den Wollenberg DJ; Emmink BL; Veenendaal LM; van Diest PJ; Hoeben RC; Borel Rinkes IH; Kranenburg O
    Cancer Gene Ther; 2008 May; 15(5):284-92. PubMed ID: 18259212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.